Solid Biosciences - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeSolid Biosciences
Solid Biosciences logo

Solid Biosciences

0 followers

SLDB

Performance

About Solid Biosciences

Solid Biosciences is a biotech company focused on advancing precision genetic medicines with a portfolio of gene therapy candidates for rare neuromuscular and cardiac diseases. The company emphasizes Duchenne muscular dystrophy and other genetic conditions, while also pursuing genetic regulators and enabling technologies to improve gene delivery. Headquartered in Charlestown, Massachusetts, Solid collaborates with researchers to develop therapies aimed at patients affected by life‑threatening neuromuscular and cardiac disorders.

Recent News

Recent Deals

No recent deals for this company.

Key Facts

HQ Location

Charlestown, United States

Founded

2013

Employees

51 - 200

Status

Public

Website

https://solidbio.com